Pharming Group Management
Management criteria checks 2/4
Pharming Group's CEO is Simon de Vries, appointed in Nov 2008, has a tenure of 15.42 years. total yearly compensation is $2.81M, comprised of 24% salary and 76% bonuses, including company stock and options. directly owns 1.27% of the company’s shares, worth €7.49M. The average tenure of the management team and the board of directors is 3.2 years and 3.1 years respectively.
Key information
Simon de Vries
Chief executive officer
US$2.8m
Total compensation
| CEO salary percentage | 24.0% |
| CEO tenure | 15.4yrs |
| CEO ownership | 1.3% |
| Management average tenure | 3.2yrs |
| Board average tenure | 3.1yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | US$3m | US$673k | -US$11m |
| Sep 30 2023 | n/a | n/a | -US$22m |
| Jun 30 2023 | n/a | n/a | -US$16m |
| Mar 31 2023 | n/a | n/a | -US$2m |
| Dec 31 2022 | US$2m | US$636k | US$14m |
| Sep 30 2022 | n/a | n/a | US$30m |
| Jun 30 2022 | n/a | n/a | US$21m |
| Mar 31 2022 | n/a | n/a | US$11m |
| Dec 31 2021 | US$3m | US$681k | US$16m |
| Sep 30 2021 | n/a | n/a | US$22m |
| Jun 30 2021 | n/a | n/a | US$31m |
| Mar 31 2021 | n/a | n/a | US$37m |
| Dec 31 2020 | US$3m | US$614k | US$38m |
| Sep 30 2020 | n/a | n/a | US$44m |
| Jun 30 2020 | n/a | n/a | US$46m |
| Mar 31 2020 | n/a | n/a | US$42m |
| Jan 01 2020 | n/a | n/a | US$41m |
| Sep 30 2019 | n/a | n/a | US$38m |
| Jun 30 2019 | n/a | n/a | US$34m |
| Mar 31 2019 | n/a | n/a | US$29m |
| Dec 31 2018 | US$2m | US$579k | US$29m |
| Sep 30 2018 | n/a | n/a | -US$29m |
| Jun 30 2018 | n/a | n/a | -US$44m |
| Mar 31 2018 | n/a | n/a | -US$80m |
| Dec 31 2017 | US$2m | US$537k | -US$91m |
Compensation vs Market: Simon's total compensation ($USD2.81M) is above average for companies of similar size in the German market ($USD1.28M).
Compensation vs Earnings: Simon's compensation has increased whilst the company is unprofitable.
CEO
Simon de Vries (64 yo)
15.4yrs
Tenure
US$2,809,000
Compensation
Dr. Sijmen De Vries, also known as Simon, M. D., M. B.A., has been the Chief Executive Officer of Pharming Group N. V. since November 03, 2008 and also serves as its Executive Director since October 13, 20...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 15.4yrs | US$2.81m | 1.27% $ 7.5m | |
| Chief Financial Officer | 3.4yrs | no data | 0.064% $ 377.7k | |
| Chief Operations Officer | 4.7yrs | no data | 0.12% $ 700.4k | |
| Investor Relations Manager | no data | no data | no data | |
| Chief Ethics & Compliance Officer | 2.9yrs | no data | 0.025% $ 144.7k | |
| Chief Medical Officer | 2.8yrs | no data | 0.027% $ 161.5k | |
| Chief Commercial Officer & GM Americas | 7.3yrs | no data | 0.028% $ 164.5k | |
| Chief Business Officer | less than a year | no data | 0.0097% $ 57.3k | |
| Consultant | 2.8yrs | no data | no data |
3.2yrs
Average Tenure
57yo
Average Age
Experienced Management: PHG's management team is considered experienced (3.2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 15.5yrs | US$2.81m | 1.27% $ 7.5m | |
| Independent Non-Executive Director | 2.9yrs | US$90.00k | 0.014% $ 83.0k | |
| Independent Non-Executive Director | 3.3yrs | US$87.00k | 0.018% $ 104.8k | |
| Independent Non-Executive Vice-Chairperson | 4.9yrs | US$87.00k | 0.020% $ 118.5k | |
| Independent Non-Executive Director | 2.9yrs | US$90.00k | 0.014% $ 83.0k | |
| Independent Non-Executive Director | 3.3yrs | US$94.00k | 0.018% $ 104.8k | |
| Non-Executive Chairman of Board | less than a year | US$46.00k | 0.0041% $ 24.1k | |
| Independent Non-Executive Director | 2.9yrs | US$94.00k | 0.014% $ 83.0k |
3.1yrs
Average Tenure
62yo
Average Age
Experienced Board: PHG's board of directors are considered experienced (3.1 years average tenure).